Key Points
- Script Botanicals products are under scrutiny: Consumers have reported severe anxiety, panic attacks, excessive sweating, and withdrawal-like symptoms after using certain newer batches of the company’s Cat’s Claw tablets.
- A fatal overdose has been linked to a Script-branded product: San Francisco health officials confirmed that MGM-15, a potent kratom-derived opioid, was detected in both a person who died of an overdose and packaging from a Script Botanicals × Maui Labs product.
- Hydrogenated mitraphylline remains an unanswered question: The name has surfaced in discussions about possible formulation changes, but its exact chemical identity, effects, and presence in the products have not been independently established.
- Product labels and laboratory certificates have limitations: A report showing that certain chemicals were not detected does not necessarily establish what other pharmacologically active ingredients a tablet contains.
- Withdrawal and overdose are both concerns: Potent opioid-active substances can produce dependence, while changes in actual product composition may leave regular consumers experiencing unexpected symptoms.
- How Brooks Helps: Brooks Healing Center provides medical detox, residential treatment, Medication-Assisted Treatment (MAT), and continuing recovery support for people struggling with opioids, 7-OH, kratom-derived compounds, and other substances.
Panic attacks, sweating so severe that clothing becomes soaked, racing heartbeats, and feelings that resemble sudden opioid withdrawal. Those are some of the experiences consumers have described after taking newer batches of Script Botanicals Cat’s Claw tablets.
For people who had previously used the products without these reactions, the sudden change has raised an obvious question: What is actually in these tablets?
That question became considerably more serious in October 2026 when the San Francisco Department of Public Health issued a warning following a fatal overdose involving MGM-15, a powerful kratom-derived opioid. Investigators identified the substance in a product sold under the Script Botanicals × Maui Labs name.
Separately, online discussions have centered on a less familiar substance called hydrogenated mitraphylline, which some consumers suspect could explain their unusual reactions. But the available research does not establish that this compound is responsible, or even confirm that it is present in the affected products.
The difference between what investigators have confirmed and what consumers suspect is important, particularly for anyone who may already be physically dependent on these tablets.
What Are Script Botanicals Cat’s Claw Tablets?
For the broader background on mislabeled products, read our guide to Cat’s Claw and undisclosed 7-OH-related opioids. This article focuses specifically on Script Botanicals, the reported reactions, and the MGM-15 finding involving a Script-branded product.
Script Botanicals markets flavored botanical tablets in a product line known as Paradise Blend. The products have been advertised as containing extracts of Uncaria tomentosa, the scientific name for Cat’s Claw.
Cat’s Claw is a woody vine native to tropical regions of Central and South America. Its bark and roots have a history of use in traditional herbal practices, and the plant contains naturally occurring compounds known as oxindole alkaloids.
One of these alkaloids is mitraphylline.
However, traditional Cat’s Claw supplements and the newer generation of psychoactive tablets sold under botanical branding are not necessarily comparable products.
Some manufacturers have marketed Cat’s Claw-branded tablets as alternatives to kratom or concentrated 7-hydroxymitragynine, commonly called 7-OH. Although the names and packaging may suggest a botanical supplement, the intended effects can resemble those associated with opioid-active substances.
This has become a growing concern as state health departments have identified powerful kratom-derived chemicals in products labeled as Cat’s Claw.
The problem isn’t that ordinary Cat’s Claw is equivalent to a synthetic opioid. It’s that a botanical name does not reliably establish the contents of every manufactured product bearing that label.
Why Are Consumers Reporting Panic Attacks and Withdrawal-Like Symptoms?
During October 2026, online consumer discussions began describing unusual reactions after the use of certain Script Botanicals products.
Some consumers reported that tablets from newer purchases produced very different effects from those they had previously experienced.
The reported symptoms included:
- Severe anxiety and sudden panic attacks
- Profuse sweating
- Rapid heartbeat and palpitations
- Restlessness and inability to relax
- Chills and changes in perceived body temperature
- Feelings of impending doom
- Little or none of the expected effects
- Symptoms described as resembling opioid withdrawal
A review published by CH3CH3 documented multiple consumer complaints posted in early October 2026, including reports involving newer bottles of Script Botanicals tablets.
These accounts should be understood as consumer reports rather than confirmed adverse reactions attributable to a particular chemical. The available documentation does not establish that every person consumed the same formulation or that the tablets caused each reported symptom.
Nevertheless, repeated accounts of unexpectedly severe reactions warrant attention, especially when the exact ingredients and their concentrations remain uncertain.
Could a Change in Ingredients Cause Withdrawal?
It is possible, although there is not enough evidence to identify the mechanism behind the reported reactions.
When someone regularly consumes an opioid-active substance, their body may gradually adapt to its presence. This adaptation can result in physical dependence, meaning that reducing or abruptly stopping exposure can produce withdrawal.
Now consider what might happen if someone purchases a new bottle of a familiar product and the chemical composition has changed.
If the previous product contained a substantial amount of an opioid-active compound and the replacement contains less, the person could experience withdrawal despite continuing to use what appears to be the same product.
Another theoretical possibility involves a compound that interferes with the effects of an opioid already occupying the body’s receptors. Certain medications and drugs can precipitate withdrawal under specific conditions, but no such mechanism has been demonstrated for the reported Script Botanicals reactions.
There are also other explanations, including unexpected stimulatory effects, another unidentified ingredient, or interactions with medications and other substances.
The symptoms themselves cannot tell us which explanation is correct. That requires laboratory identification of the actual substances involved and appropriate clinical evaluation.
For more information on how physical dependence develops, read our guide to 7-OH withdrawal symptoms and timelines.
What Is Hydrogenated Mitraphylline?
Hydrogenated mitraphylline is a name that has appeared in discussions surrounding the reactions reportedly associated with newer Script Botanicals products.
To understand why the name has attracted attention, it helps to distinguish ordinary mitraphylline from a chemically modified derivative.
Mitraphylline Is a Naturally Occurring Alkaloid
Mitraphylline is one of several oxindole alkaloids identified in Cat’s Claw and certain related botanical research.
It has been studied for potential biological activities, including anti-inflammatory effects, although research into its medical applications remains preliminary.
Importantly, mitraphylline is not the same compound as mitragynine or 7-hydroxymitragynine, two substances associated with the pharmacology of kratom.
In March 2026, researchers published a study in Frontiers in Pharmacology examining how different kratom alkaloids interact with human opioid receptors.
The researchers evaluated mitraphylline alongside several other oxindole and indole alkaloids. Under their experimental conditions, ordinary mitraphylline did not demonstrate measurable binding at the mu-, delta-, or kappa-opioid receptors.
That finding does not establish the safety of mitraphylline in every setting, but it does show why the natural alkaloid should not automatically be characterized as a powerful opioid.
What Does Hydrogenation Change?
Hydrogenation is a chemical process that adds hydrogen to a molecule. Depending on the compound and the location of the chemical modification, hydrogenation can change how that substance behaves in the body.
For example, MGM-15 is a chemically modified derivative of 7-hydroxymitragynine. It is associated with potent opioid activity and significant overdose concerns.
However, hydrogenating one alkaloid does not automatically produce the same effects as hydrogenating another.
Different molecules have different structures, and relatively small chemical modifications can alter their biological effects in unpredictable ways.
In the case of a purported substance called hydrogenated mitraphylline, several fundamental questions remain unanswered:
- What exact chemical structure does the name represent?
- Which portion of the original mitraphylline molecule has been modified?
- Does the modified substance interact with human opioid receptors?
- Could it affect the cardiovascular or nervous systems?
- Has it been independently identified in Script Botanicals tablets?
As of November 2026, publicly available research reviewed for this article does not establish a specific, independently characterized compound under that name or demonstrate its role in the reported reactions.
There is currently insufficient evidence to conclude that hydrogenated mitraphylline causes panic attacks, precipitated withdrawal, or the other symptoms being discussed by consumers.
The reports deserve investigation, but an unfamiliar chemical name should not be treated as proof of a particular mechanism.
MGM-15 Confirmed in Script Botanicals Product Following Fatal Overdose
While the questions surrounding hydrogenated mitraphylline remain unresolved, investigators have confirmed a substantially more serious finding involving a Script-branded product.
On October 21, 2026, the San Francisco Department of Public Health issued a health alert after a resident died from an overdose involving dihydro-7-hydroxymitragynine, commonly known as MGM-15.
The San Francisco Office of the Chief Medical Examiner identified MGM-15 in the deceased person’s biological specimens and in packaging from a product associated with the death.
The product was labeled Script Botanicals × Maui Labs, part of the Paradise Blend line, and was marketed as a Cat’s Claw botanical extract.
According to the health department, the packaging did not disclose kratom or 7-hydroxymitragynine.
This was not simply a consumer allegation or an unverified online laboratory report. It was a forensic finding reported by a public health agency following a fatal overdose.
The identified product was also distinct from the brands previously implicated in overdose investigations in Utah and Washington.
What Is MGM-15?
MGM-15, also called dihydro-7-hydroxymitragynine, is a semi-synthetic opioid derived from the chemistry of 7-hydroxymitragynine.
It acts as a full agonist at the mu-opioid receptor, the receptor involved in many of the effects produced by opioids such as morphine.
According to San Francisco health officials, animal research suggests MGM-15 may be approximately 15 to 50 times more potent than morphine, depending on the route of administration in those studies. These findings should not be interpreted as established human potency ratios.
Exposure to excessive amounts can cause:
- Extreme drowsiness
- Constricted pupils
- Dangerous slowing of breathing
- Loss of consciousness
- Fatal opioid overdose
MGM-15 is not approved by the FDA for medical use.
In August 2026, the Drug Enforcement Administration temporarily placed MGM-15 and related compounds into Schedule I under the Controlled Substances Act.
Brooks previously covered the emergence of this compound in our article, MGM-15: What to Know About This New Kratom-Derived Opioid.
The discovery in a Script-branded product reinforces why laboratory verification matters. A label listing a botanical extract does not rule out the presence of an undisclosed opioid.
Are Script Botanicals and Buzzers the Same Product?
No. Script Botanicals and Buzzers are separate brands, and the laboratory findings involving them should not be treated as evidence that their formulations are identical.
However, both have appeared in investigations and discussions concerning products marketed as Cat’s Claw.
In July 2026, the Utah Department of Agriculture and Food reported that investigators identified MGM-15 and mitragynine pseudoindoxyl in tested Buzzers Cat’s Claw tablets associated with severe health incidents and a death investigation.
On October 5, Utah officials issued another warning after reporting four deaths involving high-potency kratom-related chemicals found in products marketed as herbal supplements.
The San Francisco investigation later identified MGM-15 in a Script Botanicals × Maui Labs product.
These are different investigations involving different products. What connects them is the discovery of potent opioid-active compounds in products marketed using botanical terminology.
For a closer examination of the other products in this market, read our Buzzers vs. Thizziez comparison and our guide to mitragynine pseudoindoxyl versus 7-OH.
Can Script Botanicals Laboratory Certificates Prove the Tablets Are Safe?
Not necessarily.
A certificate of analysis, often abbreviated COA, is a document describing the testing performed on a particular submitted sample. It may include information about chemical identity, potency, contaminants, or the presence or absence of selected substances.
However, a certificate is only as informative as the testing that was actually performed.
For example, a laboratory might test a tablet for mitragynine, 7-OH, and several other kratom-related alkaloids. If those compounds are not detected, that result does not automatically identify every other active ingredient in the tablet.
There are several important limitations consumers should understand:
- Testing scope: A laboratory may screen only for a selected list of substances.
- Batch identification: Results from one production lot may not represent another.
- Detection limits: A substance may be present below the laboratory’s reporting threshold.
- Ingredient verification: A negative screening result does not necessarily confirm the identity or quantity of the advertised botanical ingredient.
- Independent sampling: Manufacturer-submitted samples do not necessarily establish what is present in every product available at retail.
These limitations become particularly relevant when a product’s advertised effects appear inconsistent with the ingredients disclosed on its packaging.
For products associated with unexpected reactions, comprehensive testing of retained and independently purchased samples would help determine whether chemical composition changed between batches.
Can Script Botanicals Products Cause Dependence or Withdrawal?
Products containing opioid-active compounds can cause physical dependence, although the risk associated with any particular Script Botanicals formulation depends on what that formulation actually contains.
Repeated exposure to potent opioid agonists can lead to tolerance and adaptation of the body’s opioid signaling systems.
When exposure is reduced or discontinued, a physically dependent person may experience symptoms such as anxiety, sweating, restlessness, insomnia, gastrointestinal distress, chills, and cravings.
These symptoms may overlap with the reactions consumers have reported after using newer Script Botanicals batches.
However, overlap does not establish that a person is experiencing opioid withdrawal. Panic, medication interactions, intoxication, and other medical conditions can produce similar symptoms.
Someone experiencing severe reactions should not assume that taking additional tablets will correct the problem. If the product contains an unexpected opioid or another active substance, doing so could make the situation more dangerous.
Likewise, replacing one unfamiliar botanical tablet with another is not an established method of treating withdrawal.
The safest approach for someone experiencing significant symptoms or suspected dependence is a medical evaluation that considers all substances and medications involved.
What Should Someone Do After a Bad Reaction to Script Botanicals?
Anyone experiencing unexpected symptoms after taking Script Botanicals or another Cat’s Claw-branded product should take the reaction seriously.
For severe symptoms, including chest pain, fainting, seizures, severe confusion, difficulty breathing, or an inability to remain awake, seek emergency medical care immediately.
If someone is unresponsive or not breathing normally, call 911 and administer naloxone if available. Naloxone can reverse the respiratory effects of opioid exposure, including many overdoses involving powerful synthetic or semi-synthetic opioids.
For other concerning reactions, contact a healthcare professional or Poison Control at 1-800-222-1222.
When seeking medical attention, it may help to provide the product packaging, purchase information, and details about the timing of symptoms. Healthcare professionals should also be informed about any other substances or medications the person has taken.
People who have been using these products regularly and are worried about withdrawal should seek medical guidance rather than attempting to manage significant symptoms with other unverified compounds.
Treatment for Script Botanicals, 7-OH, and Kratom-Derived Opioid Dependence
Dependence on an unfamiliar or mislabeled product can be particularly difficult because the person may not know which substances they have been taking.
Someone might believe they are using an herbal extract while actually being exposed to a compound with substantial opioid activity.
That uncertainty can complicate withdrawal management, especially when tolerance has developed or other substances are involved.
At Brooks Healing Center, our approach begins with identifying the person’s symptoms, substance use history, medical needs, and appropriate level of care.
Treatment may include medical detox to support withdrawal stabilization, followed by residential treatment when additional structure and therapeutic support are needed.
For individuals diagnosed with opioid use disorder, we also offer medications for opioid use disorder (MOUD) using FDA-approved medications when clinically appropriate.
These options include extended-release buprenorphine medications such as Sublocade and Brixadi.
Unlike experimental compounds marketed as substitutes for opioids or 7-OH, these medications have established clinical indications, dosing standards, and safety information for opioid use disorder.
They are not specifically FDA-approved to treat dependence on Script Botanicals or individual emerging kratom derivatives. A qualified medical provider determines whether treatment with buprenorphine is appropriate based on the patient’s diagnosis, clinical presentation, and substance exposure.
Treatment also addresses the circumstances that can make substance use difficult to stop, including cravings, anxiety, depression, trauma, and patterns of returning to use.
The goal is not simply to make withdrawal symptoms go away. It is to help people regain stability without relying on products whose contents or effects may be uncertain.
Frequently Asked Questions About Script Botanicals
Is Script Botanicals the same as kratom?
No. Script Botanicals products have been marketed as Cat’s Claw extracts rather than traditional kratom products. However, forensic investigators identified the kratom-derived opioid MGM-15 in a Script Botanicals × Maui Labs product, demonstrating that at least one investigated product contained an opioid-active substance not disclosed through ordinary Cat’s Claw labeling.
What causes panic attacks after taking Script Botanicals?
The cause has not been established. Possible explanations include unexpected pharmacological effects, differences in formulation, withdrawal associated with changing opioid exposure, or interactions with other substances. There is not enough evidence to identify one explanation for the reported reactions.
Does Script Botanicals contain hydrogenated mitraphylline?
That has not been independently established in the evidence reviewed for this article. The compound name has appeared in discussions about product ingredients, but publicly available research does not verify its presence in the affected tablets or explain the reported symptoms.
Is hydrogenated mitraphylline an opioid?
There is insufficient published evidence to characterize a specifically identified compound under that name as an opioid. Ordinary mitraphylline did not demonstrate measurable binding at the three major opioid receptor types in a 2026 laboratory study. Those findings cannot automatically be applied to an unspecified chemically modified derivative.
Was MGM-15 found in Script Botanicals?
Yes. San Francisco’s Office of the Chief Medical Examiner confirmed MGM-15 in material associated with a Script Botanicals × Maui Labs product and in biological specimens from a person who died of an overdose. This finding does not establish that every product or batch sold under the Script Botanicals name contains MGM-15.
Can Script Botanicals cause opioid withdrawal?
A product containing opioid-active substances could potentially cause physical dependence and withdrawal after repeated use. However, the actual ingredients and exposure history would need to be evaluated to determine whether reported symptoms are related to withdrawal or another cause.
Can naloxone reverse an MGM-15 overdose?
San Francisco health officials indicate that naloxone is expected to reverse opioid-related respiratory depression from MGM-15. Administer naloxone when an opioid overdose is suspected, call 911, and continue following emergency medical instructions. Additional doses may be needed.
Get Help for Opioid and Kratom-Derived Substance Dependence at Brooks Healing Center
The investigation into Script Botanicals raises questions that extend beyond a single product or brand.
When consumers cannot reliably identify the active ingredients in a tablet, they cannot accurately assess its potential for dependence, withdrawal, medication interactions, or overdose.
The confirmed detection of MGM-15 in a Script-branded product makes the need for transparent labeling and meaningful independent testing particularly clear. At the same time, reports involving hydrogenated mitraphylline and unexplained adverse reactions require further investigation rather than premature conclusions.
For people who have developed dependence on products marketed as Cat’s Claw, 7-OH, kratom alternatives, or other opioid-like compounds, medical support is available.
Brooks Healing Center provides comprehensive addiction treatment between Nashville and Chattanooga in Normandy, Tennessee. Our services include medical detox, residential treatment, MAT, Partial Hospitalization Program (PHP), sober living, and continuing recovery support.
If you or someone you love is struggling with these substances, call CALL NOW: 931-486-8824 to speak confidentially with our admissions team about treatment options.
You do not need to know the exact chemical name of a product to ask for help.
References
Garcia, K. (2026, October 22). Supplement sold at gas stations blamed for California man’s opioid overdose. Los Angeles Times. https://www.latimes.com/california/story/2026-10-22/supplement-sold-at-gas-stations-blamed-for-california-mans-opioid-overdose
Hemby, S. E., Rangel-Grimaldo, M., McIntosh, S., Zheng, J., Flores-Bocanegra, L., Graf, T. N., Coover, R. A., & Oberlies, N. H. (2026). Multifaceted modulation of human opioid receptors by kratom alkaloids: Binding affinity, functional selectivity, and allosteric activity. Frontiers in Pharmacology, 17, Article 1763551. https://doi.org/10.3389/fphar.2026.1763551
San Francisco Department of Public Health. (2026, October 21). Health alert: Potent new semi-synthetic opioid (MGM-15) detected in SF overdose death. https://www.sf.gov/health-alert-potent-new-semi-synthetic-opioid-mgm-15-detected-in-sf-overdose-death
U.S. Department of Justice. (2026, October 9). Department of Justice announces updates to emergency scheduling actions for 7-OH and related opioid substances. https://www.justice.gov/opa/pr/department-justice-announces-updates-emergency-scheduling-actions-7-oh-and-related-opioid
U.S. Food and Drug Administration. (2026). Hiding in plain sight: 7-OH products. https://www.fda.gov/news-events/public-health-focus/hiding-plain-sight-7-oh-products
Utah Department of Agriculture and Food. (2026, July 30). Illegal kratom product sold in Utah County linked to death in Utah. https://ag.utah.gov/news/illegal-kratom-product-sold-in-utah-county-linked-to-death-in-utah/
Utah Department of Health and Human Services. (2026, October 5). Utah health officials warn of fatal overdoses involving illegal “cat’s claw” and kratom product. https://dhhs.utah.gov/featured-news/utah-health-officials-warn-of-fatal-overdoses-involving-illegal-cats-claw-and-kratom-product/
University of Utah Health, Utah Poison Control Center. (2026, July 22). Adulterated cat’s claw and kava products may cause opioid overdose. https://poisoncontrol.utah.edu/news/2026/07/adulterated-cats-claw-and-kava-products-may-cause-opioid-overdose
CH3CH3. (2026, October). Script Botanicals: Cat’s claw tablets sold as the legal alternative to 7-OH, and the company behind them. https://ch3ch3.com/p/193
